Sign in

Mark Hartmann

@mphartmann.bsky.social
1.9K followers 4.4K following 98 posts

Scientist at DKFZ and NCT Heidelberg #epigenetics #stemcells #leukemia #colorectalcancer #multiomics #precisiononcology #oncofetal #reprogramming #plasticity www.translational-cancer-epigenomics.de

PostsRepliesMedia
Mark Hartmann @mphartmann.bsky.social · 16/04/2026
Still time to register! Looking forward to a lively discussion!
000
Mark Hartmann @mphartmann.bsky.social · 09/04/2026
Editors’ Pick by Cancer Research Catalyst @aacrjournals.bsky.social RAS-driven plasticity and oncofetal reprogramming as a key mechanism and vulnerability in JMML. The article is freely available for a limited time: www.aacr.org/blog/2026/03... #hematology #oncology #epigenetics #development
aacr.org
Editors’ Picks, March 2026: Pediatric Leukemia Development, Low-dose Tamoxifen Use, and More
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and more.
062
Mark Hartmann @mphartmann.bsky.social · 02/04/2026
Looking forward to a great scientific program with @bethpsaila.bsky.social, Simón Méndez-Ferrer, Jian Xu and many more exciting short talks. Join us on April 16 to discuss developmental programs in leukemia. @isehsociety.bsky.social
010
Mark Hartmann @mphartmann.bsky.social · 02/04/2026
Excited to present our work at the 2026 #ISEH Mini Symposium! “Beyond the Maturation Block: Oncofetal Reprogramming and Stem Cell Plasticity in Pediatric Leukemia” Join us on April 16 to discuss developmental programs in leukemia and beyond. iseh.org/Webinars-Eve...
iseh.org
Mini Symposium
172
Mark Hartmann @mphartmann.bsky.social · 04/02/2026
JMML stem cells aren’t epigenetically “stuck” in a fetal state. They mature postnatally—yet show striking transcriptional plasticity, with oncofetal reprogramming in high-risk disease, challenging the classic “maturation block” model. doi.org/10.1158/2643... #JMML #epigenetics #hematology #cancer
doi.org
Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia
AbstractPersistent fetal gene expression in childhood neoplasms is usually explained by a maturation block originating in the prenatal phase. In contrast, reactivation of fetal genes in adult malignan...
042
Mark Hartmann @mphartmann.bsky.social · 04/02/2026
Same mutation ≠ same leukemia. Wagenblast et al. show: • fetal HSCs readily transform • postnatal HSCs become resistant • fetal programs create targetable vulnerabilities Ontogeny matters: state-of-origin shapes biology & therapy response. doi.org/10.1158/2159... #pediatric #AML #stemcells
doi.org
Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia
AbstractAccumulating evidence links pediatric cancers to prenatal transformation events, yet the influence of the developmental stage on oncogenesis remains elusive. We investigated how hematopoietic ...
143
Mark Hartmann @mphartmann.bsky.social · 04/02/2026
New Spotlight in @aacrjournals.bsky.social #Oncogene × #Ontogeny × #Plasticity shape leukemia biology & therapy response. Two complementary studies show: mutations alone don’t explain disease behavior—developmental state and cellular plasticity matter. aacrjournals.org/bloodcancerd... 🩸🧬 EpiSci
aacrjournals.org
A Triumvirate of Transformation: Oncogene, Ontogeny, and Plasticity
Summary:. Cancer cells display extensive heterogeneity that influences therapy response and clinical outcome, yet the underlying mechanisms remain incompletely understood. Recent studies reveal that t...
174
Mark Hartmann @mphartmann.bsky.social · 02/02/2026
You keep us on tenterhooks, what are those exciting discoveries??? 😲 Looking forward to find out more, hopefully some time soon. 😉
110
Mark Hartmann @mphartmann.bsky.social · 28/01/2026
Absolutely, we see pronounced fetal signatures in JMML, too: aacrjournals.org/bloodcancerd... Unfortunately, LIN28B is not well captured in the scRNA data. However, I remember clusters revealing pronounced b-catenin expression patterns. Will check this again… maybe we can find shared programs.
aacrjournals.org
Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia
Abstract. Persistent fetal gene expression in childhood neoplasms is usually explained by a maturation block originating in the prenatal phase. In contrast, reactivation of fetal genes in adult malign...
110
Mark Hartmann @mphartmann.bsky.social · 28/01/2026
Exciting topic! Looking forward to reading this preprint.
110
Reposted by Mark Hartmann
Rhys Morgan @rhysmorganlab.bsky.social · 28/01/2026
Very pleased to share our latest pre-print which showcases the incredible hard work and skill of Dr Okan Sevim. Our continued exploration of β-catenin's contribution to the post transcriptional landscape of blood cells led us to a LIN28B interaction. 1/7 www.biorxiv.org/content/10.6...
biorxiv.org
Dual targeting a LIN28B:β-catenin axis in acute myeloid leukaemia
Wnt/β-catenin signalling is dysregulated across several haematological malignancies, including acute myeloid leukaemia (AML), where is lacks effective targeting strategies. Previously, we discovered that β-catenin interacts with several RNA-binding proteins (RBP), and binds mRNA indirectly, indicating contributions to the post-transcriptional landscape of leukaemia cells. Here, we found the most frequent RBP-binding motif amongst β-catenin-bound mRNAs was the GGAG motif targeted by the oncofoetal expressed miRNA-regulating RBP LIN28B. We detected the β-catenin:LIN28B interaction in lymphoid and myeloid cell lines, and primary human CD34⁺ fetal liver-derived haematopoietic stem cells. LIN28B positively regulated Wnt signalling capacity by regulating LEF1 expression through a post-transcriptional mechanism requiring the let7 miRNA axis. Further miRNA sequencing of β-catenin- and LIN28B-depleted myeloid cells revealed both potential cooperative and antagonistic function in miRNA regulation. Finally, dual-targeting both β-catenin and LIN28B through either genetic or pharmacological means preferentially killed AML cells. These data reveal a potential novel synthetically lethal relationship in AML which could be exploited in the rare AML subsets where LIN28B expression becomes reactivated ### Competing Interest Statement The authors have declared no competing interest. Kay Kendall Leukaemia Fund, https://ror.org/03j2wfg84, KKL1051, KKL1446 Leukaemia & Myeloma Research UK, 4-5/06.21R Children’s Cancer & Leukaemia Group, CCLGA 2023 16 Morgan Republic of Türkiye Ministry of National Education
2103
Mark Hartmann @mphartmann.bsky.social · 17/01/2026
Congratulations, Julius and all Co-Authors!
010
Reposted by Mark Hartmann
Reka Toth @rn-toth.bsky.social · 15/01/2026
🚨We have an opening for Data Scientists or Bioinformaticians using machine learning and AI with all kinds of molecular data to support cancer research. 🧬 Permanent position, fantastic team, exciting projects—what more could you ask for? www.lih.lu/en/job/?valu...
lih.lu
Job » Luxembourg Institute of Health
Applications including a letter detailing your motivation and a curriculum vitae should be sent through our website via the apply button below.
143
Reposted by Mark Hartmann
Andi Roy @roylab-oxford.bsky.social · 12/01/2026
Out in print this week @bloodjournal.bsky.social . Very proud of this collaborative work with Prof Karadimitris @imperialimmuno.bsky.social. Thanks to @cancerresearchuk.org and CwC_UK for funding this work. #InfantALL @paediatrics.ox.ac.uk @imm.ox.ac.uk
084
Mark Hartmann @mphartmann.bsky.social · 08/01/2026
Thanks for sharing our study! #Kinderkrebs #Leukämie @dkfz.bsky.social @nct-heidelberg.bsky.social
000
Mark Hartmann @mphartmann.bsky.social · 08/01/2026
Interesting story about the role of #oncofetal RNA-binding proteins in #immune #evasion in #ovarian #cancer.
000
Reposted by Mark Hartmann
Arnaud Krebs @arnaudkr.bsky.social · 07/01/2026
Epigenetics that matters! Very cool work on hard to hard-to-access cell types . Finally some solid epigenetics examples that should be used in textbooks! Congrats to Mathieu and team @embl.org Rome!
042
Reposted by Mark Hartmann
NCT Heidelberg @nct-heidelberg.bsky.social · 15/12/2025
Neue Erkenntnisse zu frühkindlicher Leukämie: Leukämiezellen können Programme aus der fetalen Entwicklung erneut aktivieren. Die Ergebnisse eröffnen neue Angriffspunkte für Diagnostik und Therapie. www.nct-heidelberg.de/das-nct/news... @dkfz.bsky.social @mphartmann.bsky.social @dblipka.bsky.social
073
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
Thank you so much, Tim!!! And I agree! Our first experience with Blood Cancer Discovery @aacrjournals.bsky.social was really really great. Very quick, communicative and professional, but also absolutely supportive, proactive, flexible and courteous!
040
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
Of course, it’s always a pleasure to talk to you! :)
000
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
Thanks, Tim! I will let him know… ;) unfortunately, he’s not on bluesky.
110
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
@simonhaas.bsky.social @mhaniffa.bsky.social Jan-Philipp Mallm Sam Behjati Marc-Jan Bonder @stefanfrohling.bsky.social Elliot Stieglitz Charlotte M. Niemeyer
020
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
Fatemeh Alikarami @littleoldmewi.bsky.social Jun Wang Tobias Boch @viktoriaflore.bsky.social @pavlolutsik.bsky.social @milsommick.bsky.social Simon Raffel Christian Buske
010
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
Jovana Rajak Valentin Maurer Ling Hai Katharina Bauer Mariam Hakobyan Sina Stäble Jens Langstein Laura Jardine Roland Roelz Sheila Bohler Eleonora Khabirova Abdul-Habib Maag Dominik Vonficht Dirk Lebrecht Katrin M. Bernt @kaitanlab.bsky.social Changya Chen
000
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
Fantastic environment at our host institutes @dkfz.bsky.social & @nct-heidelberg.bsky.social Thanks to all co-authors of this publication:
330
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
Deep gratitude to my friend and shared first co-author Maximilian Schönung the last authors @joschkah.bsky.social, Christian Flotho, Christoph Plass, Miriam Erlacher, Matthias Schlesner, and especially @dblipka.bsky.social
230
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
Multi-omics integration reveals risk-associated gene expression signatures, identifying CD52 as a potential therapeutic target for high-risk JMML. Anti-CD52 treatment depletes JMML stem cells and disrupts disease propagation in a JMML PDX model.
120
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
RAS-pathway mutations induce fetal-like gene expression programs in a JMML mouse model, suggesting RAS-driven oncofetal reprogramming in murine JMML stem cells.
120
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
Fetal HSC signatures are enriched in patients without detectable JMML driver mutations at birth.
120
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
JMML stem cells show transcriptional plasticity, hijacking parts of distinct developmental programs, including fetal HSC marker genes, leading to mosaic-like developmental expression programs. This suggests the reactivation rather than preservation of oncofetal signatures.
120
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
The postnatal maturation state of JMML stem cells challenges the universality of the maturation block model in pediatric malignancies.
120
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
JMML epitypes are prognostic biomarkers in JMML. Conservation of such disease-specific epigenetic signatures in HSC-like JMML stem cells and downstream immune cells suggests HSCs or early HSPCs as the cells-of-origin in JMML across JMML epitypes.
210
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
Epigenomes encode cell type, developmental state, and disease-specific information. DNA methylomes of JMML stem cells reveal: 1. HSC-like cell type signatures 2. A postnatal maturation state 3. Disease-specific epitypes
120
Mark Hartmann @mphartmann.bsky.social · 06/12/2025
ONLINE FIRST ALERT! Molecular #Plasticity Results in #Oncofetal #Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia aacrjournals.org/bloodcancerd... @aacrjournals.bsky.social #childhoodcancer #epigenetics #precisiononcology
3216
Mark Hartmann @mphartmann.bsky.social · 12/11/2025
Looks awesome!
000
Mark Hartmann @mphartmann.bsky.social · 27/10/2025
Congratulations, Rolf & Team! Very interesting story!
110
Mark Hartmann @mphartmann.bsky.social · 22/10/2025
Pipeline Olympics for DNA methylation data Check this out: doi.org/10.1093/nar/... Important study from @rn-toth.bsky.social & @pavlolutsik.bsky.social Published @narjournal.bsky.social #epigenetics #methylation #bioinformatics
doi.org
Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standard
Abstract. DNA methylation is a widely studied epigenetic mark and a powerful biomarker of cell type, age, environmental exposures, and disease. Whole-genom
0103
Mark Hartmann @mphartmann.bsky.social · 07/10/2025
Super interesting!
010
Mark Hartmann @mphartmann.bsky.social · 07/10/2025
7) gurken (grk) [german for cucumbers 🥒] TGF-alpha-like in Drosophila, fundamental for developmental axis specification during egg formation
010
Mark Hartmann @mphartmann.bsky.social · 07/10/2025
Important work!
010
Mark Hartmann @mphartmann.bsky.social · 07/10/2025
No #nobelpize @bsky.app !? @nobelprize.bsky.social is an empty desert… Pity! #science #research
020
Mark Hartmann @mphartmann.bsky.social · 01/10/2025
Cool new single-cell multi-omics tool! #epigenetics
030
Mark Hartmann @mphartmann.bsky.social · 29/09/2025
Nice story – thanks for sharing!
010
Mark Hartmann @mphartmann.bsky.social · 26/09/2025
In German: www.forschung-und-lehre.de/karriere/pau...
forschung-und-lehre.de
Paul Ehrlich-Preis geht an zwei Entwicklungsbiologen
Zwei Pioniere der Epigenetik werden geehrt. Davor Solter und Azim Surani haben das Phänomen der genomischen Prägung entdeckt.
020
Mark Hartmann @mphartmann.bsky.social · 26/09/2025
Further reading: www.goethe-university-frankfurt.de/96873415/Pau...
goethe-university-frankfurt.de
Goethe-Universität — Paul Ehrlich Foundation
110
Mark Hartmann @mphartmann.bsky.social · 26/09/2025
Pioneers of Epigenetics honored: Davor Solter & Azim Surani receive the 2026 Paul Ehrlich & Ludwig Darmstaedter Prize. Their discovery of genomic imprinting revealed why mammals need both parents—opening the field of epigenetics. #Epigenetics #GenomicImprinting #PaulEhrlichPrize #CanSky #Science
1141
Mark Hartmann @mphartmann.bsky.social · 15/08/2025
Awesome - congratulations!
010
Mark Hartmann @mphartmann.bsky.social · 17/07/2025
The German Science and Humanities Council declares permanent positions the new standard. Interview with @wickwolfgang.bsky.social & Insa Großkraumbach @wissenschaftsrat.de A must-read for all working in higher education and research in Germany! #Wissenschaft #Forschung #WissZeitVG #IchBinHanna
0122
Mark Hartmann @mphartmann.bsky.social · 17/07/2025
Entscheidend wird sein, dass Projektbezüge nicht weiter als formale Begründung für Befristungen dienen – ein strukturelles Problem, das das #WissZeitVG bislang erlaubt. Jetzt ist die Chance, das zu ändern. #Hochschulpolitik #Forschung
010
Mark Hartmann @mphartmann.bsky.social · 17/07/2025
Wissenschaftliche Karrieren jenseits der Professur brauchen endlich strukturelle Anerkennung. Dauerhafte Forschung & Lehre brauchen dauerhafte Perspektiven – nicht endlose Projektbefristungen.
110